Skip to main content
logo
Semnur Pharmaceuticals, Inc. (SMNR)
OTCMKTS · Delayed Price · Currency is USD
0.5990
+0.1365 (29.51%)
At close: Sep 25, 2026

Semnur Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
1383,4463972111
Market Cap Growth
-97.52%8625.86%-45.38%-35.07%-
Enterprise Value
1613,45681--
Last Close Price
0.6015.0011.8810.1710.29

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
PB Ratio
-4.65-166.08-0.92-1.90-3.20

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
-0.78-0.74-1.15-0.99-1.02
Net Debt / Equity Ratio
-0.78-0.74-1.15-0.99-1.01
Quick Ratio
0.000.000.340.010.14
Current Ratio
0.110.06171.290.020.37
Return on Assets (ROA)
-1900.20%-2497.14%-79.36%-278.24%-
Return on Capital Employed (ROCE)
1919.50%1818.40%-70.50%1689.60%-664.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-121.60%-4.66%-11.88%-4.51%-3.38%
Buyback Yield / Dilution
0.05%-2.39%-25.00%--